A Dark Vector Cognition product

Item 2. PROPERTIES

2K characters. Original on sec.gov · Markdown

Item 2. PROPERTIES

The Company owns the following properties:

LocationNature of Property
United States:
Washington, SeattleCorporate headquarters
California, BrisbaneOffice and warehouse building
California, HawthorneOffice and warehouse building
Florida, MiamiOffice and warehouse building
Illinois, BensenvilleOffice and warehouse building
New Jersey, EdisonOffice and warehouse building
New York, InwoodOffice and warehouse building
Texas, HumbleOffice and warehouse building
Washington, SeaTacOffice building
Washington, SpokaneOffice building
North Asia:
China, BeijingOffice and warehouse building
China, ShanghaiOffice building
China, ShenzhenOffices
China, TianjinOffices
Hong Kong, KowloonOffices
Korea, SeoulOffice and warehouse
Taiwan, TaipeiOffices
Europe:
Belgium, BrusselsOffice and warehouse building
England, LondonOffice and warehouse building
Ireland, CorkOffice and warehouse building
Ireland, DublinOffice and warehouse building
Other North America:
Mexico, Nuevo LaredoLand
Latin America:
Costa Rica, AlajuelaOffice building
Middle East:
Egypt, CairoOffice and warehouse building

The Company leases and maintains nearly 80 additional offices and warehouse locations in the United States and approximately 400 leased locations worldwide, primarily located close to an airport, ocean port, or on an important border crossing. The majority of these facilities contain warehouse facilities. Lease terms are either on a month-to-month basis or terminate at various times through 2025. See Note 8 to the Company’s consolidated financial statements for lease commitments. The Company will investigate the possibility of building or buying suitable facilities. The Company believes that current leases can be extended and that suitable alternative facilities are available in the vicinity of each present facility should extensions be unavailable at the conclusion of current leases.

| 13.

Previous: Item 1B. UNRESOLVED STAFF COMMENTS · Next: Item 3. LEGAL PROCEEDINGS